И. М. Хаертынова

520 total citations
24 papers, 208 citations indexed

About

И. М. Хаертынова is a scholar working on Infectious Diseases, Epidemiology and Ecology, Evolution, Behavior and Systematics. According to data from OpenAlex, И. М. Хаертынова has authored 24 papers receiving a total of 208 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Infectious Diseases, 6 papers in Epidemiology and 4 papers in Ecology, Evolution, Behavior and Systematics. Recurrent topics in И. М. Хаертынова's work include Viral Infections and Vectors (10 papers), SARS-CoV-2 and COVID-19 Research (5 papers) and Viral Infections and Outbreaks Research (5 papers). И. М. Хаертынова is often cited by papers focused on Viral Infections and Vectors (10 papers), SARS-CoV-2 and COVID-19 Research (5 papers) and Viral Infections and Outbreaks Research (5 papers). И. М. Хаертынова collaborates with scholars based in Russia, United States and United Kingdom. И. М. Хаертынова's co-authors include Amanda Paschke, Jay A. Grobler, Svetlana F. Khaiboullina, Michelle Brown, Carisa De Anda, Julie Strizki, Ekaterina Martynova, Albert A. Rizvanov, Sei Won Kim and Wei Gao and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and International Journal of Molecular Sciences.

In The Last Decade

И. М. Хаертынова

21 papers receiving 199 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
И. М. Хаертынова Russia 8 163 51 32 22 21 24 208
Boyun Liang China 8 197 1.2× 34 0.7× 22 0.7× 25 1.1× 27 1.3× 18 231
Weilie Chen China 8 69 0.4× 29 0.6× 41 1.3× 5 0.2× 5 0.2× 17 138
Yang Yuan China 6 144 0.9× 10 0.2× 6 0.2× 47 2.1× 34 1.6× 10 169
Chayada Piantham Japan 5 179 1.1× 21 0.4× 10 0.3× 10 0.5× 7 233
Roy Avraham Israel 8 87 0.5× 66 1.3× 22 0.7× 1 0.0× 17 0.8× 11 209
Grace M. Vahey United States 6 103 0.6× 6 0.1× 26 0.8× 4 0.2× 31 1.5× 12 149
Gigi Y.Z. Liu Hong Kong 6 141 0.9× 22 0.4× 13 0.4× 5 0.2× 1 0.0× 8 195
Mihaela Zaharia Romania 5 55 0.3× 24 0.5× 8 0.3× 3 0.1× 4 0.2× 7 85
Ricardo Ariel Zimerman Brazil 8 200 1.2× 63 1.2× 19 0.6× 3 0.1× 14 241
Yano Yoga Australia 4 156 1.0× 31 0.6× 8 0.3× 4 0.2× 1 0.0× 4 204

Countries citing papers authored by И. М. Хаертынова

Since Specialization
Citations

This map shows the geographic impact of И. М. Хаертынова's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by И. М. Хаертынова with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites И. М. Хаертынова more than expected).

Fields of papers citing papers by И. М. Хаертынова

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by И. М. Хаертынова. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by И. М. Хаертынова. The network helps show where И. М. Хаертынова may publish in the future.

Co-authorship network of co-authors of И. М. Хаертынова

This figure shows the co-authorship network connecting the top 25 collaborators of И. М. Хаертынова. A scholar is included among the top collaborators of И. М. Хаертынова based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with И. М. Хаертынова. И. М. Хаертынова is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Garanina, Ekaterina, И. М. Хаертынова, Maria Markelova, et al.. (2024). Cross‐reactivity of hantavirus antibodies after immunization with PUUV antigens. Biotechnology and Applied Biochemistry. 71(5). 1139–1153. 1 indexed citations
2.
Martynova, Ekaterina, Yuriy Davidyuk, Maria Markelova, et al.. (2023). Differential Cytokine Responses and the Clinical Severity of Adult and Pediatric Nephropathia Epidemica. International Journal of Molecular Sciences. 24(8). 7016–7016. 2 indexed citations
3.
Johnson, Matthew G., Julie Strizki, Michelle Brown, et al.. (2023). Molnupiravir for the treatment of COVID-19 in immunocompromised participants: efficacy, safety, and virology results from the phase 3 randomized, placebo-controlled MOVe-OUT trial. Infection. 51(5). 1273–1284. 23 indexed citations
5.
Martynova, Ekaterina, Ekaterina Garanina, И. М. Хаертынова, et al.. (2023). Neutralizing Antibodies in COVID-19 Serum from Tatarstan, Russia. International Journal of Molecular Sciences. 24(12). 10181–10181.
6.
Garanina, Ekaterina, Ekaterina Martynova, Maria Markelova, et al.. (2022). Antibody and T Cell Immune Responses to SARS-CoV-2 Peptides in COVID-19 Convalescent Patients. Frontiers in Microbiology. 13. 842232–842232. 3 indexed citations
7.
Arribas, José Ramón, Sanjay Bhagani, Suzana M. Lobo, et al.. (2021). Randomized Trial of Molnupiravir or Placebo in Patients Hospitalized with Covid-19. NEJM Evidence. 1(2). EVIDoa2100044–EVIDoa2100044. 86 indexed citations
8.
Martynova, Ekaterina, Ekaterina Garanina, Maria Markelova, et al.. (2021). Long Term Immune Response Produced by the SputnikV Vaccine. International Journal of Molecular Sciences. 22(20). 11211–11211. 9 indexed citations
11.
Хаертынова, И. М., et al.. (2020). Clinical and epidemiological features chronic hepatitis C in children. 9(1). 57–62.
12.
Мартынова, Е. В., et al.. (2019). Analysis of markers of renal damage in patients with hantaan hemorrhagic fever. Practical medicine. 17(8). 97–102. 2 indexed citations
14.
Davidyuk, Yuriy, Ekaterina Martynova, Ruzilya Ismagilova, et al.. (2019). Characterization of the Puumala orthohantavirus Strains in the Northwestern Region of the Republic of Tatarstan in Relation to the Clinical Manifestations in Hemorrhagic Fever With Renal Syndrome Patients. Frontiers in Pharmacology. 10. 970–970. 7 indexed citations
15.
Martynova, Ekaterina, Yuriy Davidyuk, Ekaterina Garanina, et al.. (2019). Δccr5 Genotype Is Associated with Mild Form of Nephropathia Epidemica. Viruses. 11(7). 675–675. 3 indexed citations
16.
Хаертынова, И. М., et al.. (2019). Interaction of hepatitis C virus with the immune system in pregnant women with chronic hepatitis C. SHILAP Revista de lepidopterología. 13(1). 43–49. 1 indexed citations
17.
Martynova, Ekaterina, Adelya Maksudova, Sayar Abdulkhakov, et al.. (2018). Urinary Clusterin Is Upregulated in Nephropathia Epidemica. Disease Markers. 2018. 1–7. 9 indexed citations
18.
Valiullina, Aygul, Ekaterina Martynova, Oleg Gusev, et al.. (2017). Positive Correlation between Serum Tryglycerides and Pro-Inflammatory Cytokines in Hemorrhagic Fever with Renal Syndrome. Blood. 130. 4818–4818. 1 indexed citations
19.
Martynova, Ekaterina, Oleg Gusev, Yuriy Davidyuk, et al.. (2016). High Triglycerides Are Associated with Low Thrombocyte Counts and High VEGF in Nephropathia Epidemica. Journal of Immunology Research. 2016. 1–11. 5 indexed citations
20.
Shuralev, Eduard A., Sergey P. Morzunov, И. М. Хаертынова, et al.. (2015). Epidemiological dynamics of nephropathia epidemica in the Republic of Tatarstan, Russia, during the period of 1997–2013. Epidemiology and Infection. 144(3). 618–626. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026